Cases & Investigations

In re Niaspan Antitrust Litigation

CASE NUMBER: 2:13-md-02460
PRACTICE AREAS: Antitrust
PRODUCT: Niaspan (extended release niacin)
CASE STATUS: Pending
COURT: United States District Court for the Eastern District of Pennsylvania

On December 23, 2013, Berger Montague was appointed co-lead counsel in this class action challenging a pay for delay deal concerning the brand name drug Niaspan (extended release niacin). On September 8, 2014, the Honorable Jan E. DuBois denied defendants’ motion to dismiss. Discovery is underway.

Lead Attorneys: David F. Sorensen, Nick Urban

Lead Attorneys

David Sorensen Headshot

David F. Sorensen

Managing Shareholder

Associates

Request A Free Consultation

  • This field is for validation purposes and should be left unchanged.